Filing Details
- Accession Number:
- 0001567619-21-014768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-09 17:00:59
- Reporting Period:
- 2021-08-05
- Accepted Time:
- 2021-08-09 17:00:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1800619 | Nimrata Hunt | Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-05 | 27 | $67.85 | 8,133 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-05 | 511 | $141.60 | 8,644 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-05 | 538 | $703.00 | 8,106 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-05 | 27 | $0.00 | 27 | $67.85 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-05 | 511 | $0.00 | 511 | $141.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-13 | No | 4 | M | Direct | |
| 1,218 | 2027-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 160 | Indirect | jointly with spouse |
Footnotes
- Includes a total of 23.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
- Grant of option to buy 1,940 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017.
- Grant of option to buy 3,579 shares of Issuer common stock that vest in five annual installments beginning on February 14, 2018.
- Not applicable.
Billionaire Hedge Funds
